Avricore Health (AVCRF) Revenue (2009 - 2025)

Avricore Health has disclosed Revenue across 16 years of filings, most recently posting $27379.6 for Q3 2025.

• In Q3 2025, Revenue fell 96.87% year-over-year to $27379.6; the TTM figure through Sep 2025 stood at $1.2 million (down 64.64% YoY), while the FY2025 annual figure was $382112.2, down 89.07% from the prior year.
• Revenue climbed to $27379.6 in Q3 2025, from $20707.4 in the prior quarter.
• Over the last five years, Revenue for AVCRF reached as high as $994857.1 in Q4 2023 and fell as low as $4018.0 in Q2 2021.
• The 5-year median for Revenue is $355250.3 (2025), against an average of $379607.6.
• Annual changes were most pronounced in 2021 — Revenue tumbled 98.68% — and 2022, when it soared 3339.05%.
• A 5-year view of Revenue shows it stood at $27917.5 in 2021, then surged by 2478.78% to $719931.9 in 2022, then soared by 38.19% to $994857.1 in 2023, then decreased by 11.94% to $876088.3 in 2024, then plunged by 96.87% to $27379.6 in 2025.
• According to Business Quant data, Revenue over the past three periods registered $27379.6, $20707.4, and $302504.3 for Q3 2025, Q2 2025, and Q1 2025 respectively.